Ryman Healthcare enjoyed its best week in almost two years.
The honey and wellness company has been getting advice on the matter, but an AGM question brought topic to the surface.
Listed car dealer accepts errors made on corporate governance, but argues penalty too high.
NZSA asks ‘how much is too much?’ for exec pay scheme; intends to vote against.
The verification of the company's dried flower product has been delayed.
Company considering implications of proposed change to regulate lab-developed tests like Cxbladder.
NZX-listed software company says UK partner can’t pay up; ASB to review lending.
The retailer delivered revenue growth but warned about slowing sales.
Shareholder happy with lower debt level, but board can’t commit to keeping it there.
The Warehouse will no longer be supplied Weet-Bix from later this week.
